Dan Brennan
Stock Analyst at TD Cowen
(4.37)
# 357
Out of 5,113 analysts
126
Total ratings
56.7%
Success rate
16.98%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Buy | $654 → $696 | $608.02 | +14.47% | 14 | Jan 7, 2026 | |
| ILMN Illumina | Maintains: Hold | $115 → $140 | $149.86 | -6.58% | 14 | Jan 7, 2026 | |
| DHR Danaher | Maintains: Buy | $260 → $270 | $224.54 | +20.25% | 7 | Jan 7, 2026 | |
| BRKR Bruker | Maintains: Hold | $42 → $53 | $46.55 | +13.86% | 3 | Jan 7, 2026 | |
| TXG 10x Genomics | Maintains: Hold | $15 → $18 | $21.08 | -14.61% | 5 | Jan 7, 2026 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $11.05 | +8.60% | 4 | Jan 7, 2026 | |
| MDXH MDxHealth | Maintains: Buy | $5 → $7 | $3.65 | +91.78% | 2 | Nov 13, 2025 | |
| WAT Waters | Maintains: Hold | $345 → $390 | $385.03 | +1.29% | 4 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $74 → $90 | $102.25 | -11.98% | 7 | Nov 4, 2025 | |
| MYGN Myriad Genetics | Maintains: Hold | $8 → $9 | $5.72 | +57.34% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $162 | $133.87 | +21.01% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $72 | $109.73 | -34.38% | 3 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $12.38 | -3.07% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $18.50 | -18.92% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $26.50 | +20.75% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $95.29 | +15.44% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.42 | -26.90% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $64.57 | +14.60% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $235.93 | -25.83% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $216.88 | +15.27% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $111.13 | +29.58% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $39.41 | +29.41% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $10.33 | +442.11% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $180.35 | +202.74% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $2.38 | +530.25% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $186.32 | +24.52% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,401.64 | -37.22% | 3 | Oct 7, 2020 |
Thermo Fisher Scientific
Jan 7, 2026
Maintains: Buy
Price Target: $654 → $696
Current: $608.02
Upside: +14.47%
Illumina
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $149.86
Upside: -6.58%
Danaher
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $224.54
Upside: +20.25%
Bruker
Jan 7, 2026
Maintains: Hold
Price Target: $42 → $53
Current: $46.55
Upside: +13.86%
10x Genomics
Jan 7, 2026
Maintains: Hold
Price Target: $15 → $18
Current: $21.08
Upside: -14.61%
Avantor
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $11.05
Upside: +8.60%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.65
Upside: +91.78%
Waters
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $385.03
Upside: +1.29%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $102.25
Upside: -11.98%
Myriad Genetics
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $5.72
Upside: +57.34%
Oct 14, 2025
Maintains: Buy
Price Target: $150 → $162
Current: $133.87
Upside: +21.01%
Sep 25, 2025
Maintains: Buy
Price Target: $63 → $72
Current: $109.73
Upside: -34.38%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $12.38
Upside: -3.07%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $18.50
Upside: -18.92%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $26.50
Upside: +20.75%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $95.29
Upside: +15.44%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.42
Upside: -26.90%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $64.57
Upside: +14.60%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $235.93
Upside: -25.83%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $216.88
Upside: +15.27%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $111.13
Upside: +29.58%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $39.41
Upside: +29.41%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $10.33
Upside: +442.11%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $180.35
Upside: +202.74%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $2.38
Upside: +530.25%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $186.32
Upside: +24.52%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,401.64
Upside: -37.22%